Ardelyx | ARDX - Selling And Administration Expenses

Stock Price
5.95
Daily Change
-0.01 -0.17%
Monthly
5.50%
Yearly
13.12%
Q2 Forecast
5.82

Ardelyx reported $75.92M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Abbott USD 3.27B 138M Mar/2026
Amgen USD 1.94B 237M Dec/2025
Ardelyx USD 75.92M 7.69M Dec/2025
aTyr Pharma USD 82.26M 77.46M Dec/2025
Corcept Therapeutics USD 114.74M 7.77M Dec/2025
Curis USD 1.34M 3.45M Dec/2025
Sanofi EUR 2.75B 455M Dec/2025
TG Therapeutics USD 50.73M 12.64M Dec/2025
United Therapeutics USD 190.6M 38.6M Dec/2025
Xoma USD 11M 2.54M Jun/2024